188 related articles for article (PubMed ID: 11861286)
1. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide.
Nagai Y; Shimazu R; Ogata H; Akashi S; Sudo K; Yamasaki H; Hayashi S; Iwakura Y; Kimoto M; Miyake K
Blood; 2002 Mar; 99(5):1699-705. PubMed ID: 11861286
[TBL] [Abstract][Full Text] [Related]
2. The RP105/MD-1 complex is indispensable for TLR4/MD-2-dependent proliferation and IgM-secreting plasma cell differentiation of marginal zone B cells.
Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Ohta S; Hirai Y; Kimoto M; Miyake K; Takatsu K
Int Immunol; 2012 Jun; 24(6):389-400. PubMed ID: 22354914
[TBL] [Abstract][Full Text] [Related]
3. Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1.
Miyake K; Ogata H; Nagai Y; Akashi S; Kimoto M
J Endotoxin Res; 2000; 6(5):389-91. PubMed ID: 11521060
[TBL] [Abstract][Full Text] [Related]
4. The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells.
Ogata H; Su I; Miyake K; Nagai Y; Akashi S; Mecklenbräuker I; Rajewsky K; Kimoto M; Tarakhovsky A
J Exp Med; 2000 Jul; 192(1):23-9. PubMed ID: 10880523
[TBL] [Abstract][Full Text] [Related]
5. CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.
Yazawa N; Fujimoto M; Sato S; Miyake K; Asano N; Nagai Y; Takeuchi O; Takeda K; Okochi H; Akira S; Tedder TF; Tamaki K
Blood; 2003 Aug; 102(4):1374-80. PubMed ID: 12714520
[TBL] [Abstract][Full Text] [Related]
6. Role of TLR4/MD-2 and RP105/MD-1 in innate recognition of lipopolysaccharide.
Kimoto M; Nagasawa K; Miyake K
Scand J Infect Dis; 2003; 35(9):568-72. PubMed ID: 14620136
[TBL] [Abstract][Full Text] [Related]
7. A Novel Gene Delivery Vector of Agonistic Anti-Radioprotective 105 Expressed on Cell Membranes Shows Adjuvant Effect for DNA Immunization Against Influenza.
Yamazaki T; Biswas M; Kosugi K; Nagashima M; Inui M; Tomono S; Takagi H; Ichimonji I; Nagaoka F; Ainai A; Hasegawa H; Chiba J; Akashi-Takamura S
Front Immunol; 2020; 11():606518. PubMed ID: 33414788
[TBL] [Abstract][Full Text] [Related]
8. The radioprotective 105/MD-1 complex links TLR2 and TLR4/MD-2 in antibody response to microbial membranes.
Nagai Y; Kobayashi T; Motoi Y; Ishiguro K; Akashi S; Saitoh S; Kusumoto Y; Kaisho T; Akira S; Matsumoto M; Takatsu K; Miyake K
J Immunol; 2005 Jun; 174(11):7043-9. PubMed ID: 15905547
[TBL] [Abstract][Full Text] [Related]
9. RP105 is associated with MD-1 and transmits an activation signal in human B cells.
Miura Y; Shimazu R; Miyake K; Akashi S; Ogata H; Yamashita Y; Narisawa Y; Kimoto M
Blood; 1998 Oct; 92(8):2815-22. PubMed ID: 9763566
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory responses increase secretion of MD-1 protein.
Thomas Jennings R; Odkhuu E; Nakashima A; Morita N; Kobayashi T; Yamai I; Tanaka M; Suganami T; Haga S; Ozaki M; Watanabe Y; Nagai Y; Takatsu K; Kikuchi-Ueda T; Ichimonji I; Ogawa Y; Takagi H; Yamazaki T; Miyake K; Akashi-Takamura S
Int Immunol; 2016 Oct; 28(10):503-512. PubMed ID: 27352793
[TBL] [Abstract][Full Text] [Related]
11. PTEN and PI-3 kinase inhibitors control LPS signaling and the lymphoproliferative response in the CD19+ B cell compartment.
Singh AR; Peirce SK; Joshi S; Durden DL
Exp Cell Res; 2014 Sep; 327(1):78-90. PubMed ID: 24881819
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of TLR-4/MD-2 signaling by RP105/MD-1.
Divanovic S; Trompette A; Atabani SF; Madan R; Golenbock DT; Visintin A; Finberg RW; Tarakhovsky A; Vogel SN; Belkaid Y; Kurt-Jones EA; Karp CL
J Endotoxin Res; 2005; 11(6):363-8. PubMed ID: 16303092
[TBL] [Abstract][Full Text] [Related]
13. TLR accessory molecule RP105 (CD180) is involved in post-interventional vascular remodeling and soluble RP105 modulates neointima formation.
Karper JC; Ewing MM; de Vries MR; de Jager SC; Peters EA; de Boer HC; van Zonneveld AJ; Kuiper J; Huizinga EG; Brondijk TH; Jukema JW; Quax PH
PLoS One; 2013; 8(7):e67923. PubMed ID: 23844130
[TBL] [Abstract][Full Text] [Related]
14. Vav proteins are required for B-lymphocyte responses to LPS.
Hebeis B; Vigorito E; Kovesdi D; Turner M
Blood; 2005 Jul; 106(2):635-40. PubMed ID: 15811961
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of mouse and human RP105/MD-1 complexes reveal unique dimer organization of the toll-like receptor family.
Ohto U; Miyake K; Shimizu T
J Mol Biol; 2011 Nov; 413(4):815-25. PubMed ID: 21959264
[TBL] [Abstract][Full Text] [Related]
16. MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components.
Dziarski R; Wang Q; Miyake K; Kirschning CJ; Gupta D
J Immunol; 2001 Feb; 166(3):1938-44. PubMed ID: 11160242
[TBL] [Abstract][Full Text] [Related]
17. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105.
Divanovic S; Trompette A; Atabani SF; Madan R; Golenbock DT; Visintin A; Finberg RW; Tarakhovsky A; Vogel SN; Belkaid Y; Kurt-Jones EA; Karp CL
Nat Immunol; 2005 Jun; 6(6):571-8. PubMed ID: 15852007
[TBL] [Abstract][Full Text] [Related]
18. MHC class II molecules control murine B cell responsiveness to lipopolysaccharide stimulation.
Rodo J; Gonçalves LA; Demengeot J; Coutinho A; Penha-Gonçalves C
J Immunol; 2006 Oct; 177(7):4620-6. PubMed ID: 16982900
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD180 (RP105) activates B cells to rapidly produce polyclonal Ig via a T cell and MyD88-independent pathway.
Chaplin JW; Kasahara S; Clark EA; Ledbetter JA
J Immunol; 2011 Oct; 187(8):4199-209. PubMed ID: 21918197
[TBL] [Abstract][Full Text] [Related]
20. Intracellular TLR4/MD-2 in macrophages senses Gram-negative bacteria and induces a unique set of LPS-dependent genes.
Shibata T; Motoi Y; Tanimura N; Yamakawa N; Akashi-Takamura S; Miyake K
Int Immunol; 2011 Aug; 23(8):503-10. PubMed ID: 21712422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
